Danaher Corporation management check
DHR · Health Care · Life Sciences Tools & Services · CEO Montgomery Julie A Sawyer (since the last proxy; previously Rainer Blair)
Filings as of
Closest peers in Life Sciences Tools & Services
- 101WATWaters Corporation76
- 108MTDMettler Toledo76
- 151DHRDanaher Corporation72
- 168IQVIQVIA71
- 307TMOThermo Fisher Scientific61
- 375CRLCharles River Laboratories56
- 386AAgilent Technologies55
- 443ILMNIllumina, Inc.47
- 453TECHBio-Techne45
The seven checks
- WatchTrailed its chosen peers
Have owners done well?
What $100 became since fiscal 2021
2633rdDetail
$100 invested at the start of fiscal 2021 grew to $119, against $148 for the peer group the company picked itself.
- GoodPay rose and fell with returns
Does pay follow performance?
Pay actually paid $100 value, each on its own scale
9892ndDetail
Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.96 with shareholder return. 1 means pay moved in step; below 0, the opposite way.
- Good0.7% of net income
What does the CEO cost owners?
$23.8m pay · $3.6bn net income, FY2025
6566thDetail
$23.8m of reported pay in fiscal 2025, against $3.6bn of net income.
- WatchNew CEO since the proxy
Do they own the stock?
Montgomery Julie A Sawyer: 21,960 shares ≈ $5.1m
6 mo: ▲ $0 bought · ▼ $26.1m sold
——Detail
Montgomery Julie A Sawyer filed as President & CEO after the last proxy (which named Rainer Blair) and holds 21,960 shares, about $5.1m. Their pay will be in the next proxy. 4 insiders sold $26.1m in the last six months and none bought.
- GoodShare count shrinking
Are owners being diluted?
Diluted shares −1.8% a year; flagged above +2%
Stock pay 1.2% of revenue
7365thDetail
Diluted shares changed -1.8% a year over the last three fiscal years. Stock-based pay was 1.2% of revenue in the latest year.
- WatchNew CEO: Montgomery Julie A Sawyer
Is leadership stable?
11 filings under 8-K 5.02 in 3 years
CEO: Rainer Blair → Montgomery Julie A Sawyer (new)
7046thDetail
Montgomery Julie A Sawyer has filed as CEO since the last proxy. CEO in the pay table: Rainer Blair. 11 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.
- GoodNo red flags on file
Are the books clean?
Since 2021
- 0Restated
- 0Auditor changes
- 0Late filings
- 010-K amended
100100thDetail
No restatements, auditor changes or late filings since 2021.
Reading the scores
Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.
Hover a chart for its figures. Detail has the full reading.
Pay versus performance
From the proxy statement filed March 25, 2026.
Pay tied most to Adjusted EPS
Other key measuresAbsolute TSRRelative TSR compared to S&P 500 TSRAdjusted EPS (non-GAAP)Adjusted Free Cash Flow to Adjusted Net Income Ratio (non-GAAP)Core Revenue Growth (non-GAAP)
Show the figures
| Fiscal year | CEO | CEO pay | Actually paid | Other executives (avg) | $100 became | Peers | Net income |
|---|---|---|---|---|---|---|---|
| 2025 | Rainer Blair | $23.8m | $17.3m | $9.2m | $119 | $148 | $3.6bn |
| 2024 | Rainer Blair | $22.1m | $7.5m | $6.7m | $119 | $129 | $3.9bn |
| 2023 | Rainer Blair | $20.9m | $5.2m | $7.1m | $119 | $126 | $4.8bn |
| 2022 | Rainer Blair | $20.2m | $190k | $6.6m | $120 | $124 | $7.2bn |
| 2021 | Rainer Blair | $17.2m | $59.5m | $6.2m | $149 | $126 | $6.4bn |
Insiders and the CEO's stakeSelling
- President & CEO
- Montgomery Julie A Sawyer
- Shares held
- 21,960
- At that filing's price
- ≈ $5.1m
- Latest Form 4
- Nov 15, 2026
4 insiders sold $26.1m in the last six months and none bought.
Open-market trades by officers and directors since May 21, 2026.
- SoldRainer BlairPresident & CEO$12.7mAug 21, 2026
- SoldMatthew McGrewExecutive Vice President$11.1mNov 9, 2026
- SoldChristopher BoudaVP, Chief Accounting Officer$1.8mOct 28, 2026
- SoldGregory M MilosevichExecutive Vice President$484kNov 9, 2026
Leadership and governance on file
All 15 filings
- Oct 13, 2026Leadership change8-K 5.02
- Aug 3, 2026Leadership change8-K 5.02
- May 7, 2026Leadership change8-K 5.02
- Feb 10, 2026Leadership change8-K 5.02
- Nov 6, 2025Leadership change8-K 5.02
- Jul 31, 2025Leadership change8-K 5.02
- Jul 24, 2025Leadership change8-K 5.02
- Feb 20, 2025Leadership change8-K 5.02
- Dec 11, 2024Leadership change8-K 5.02
- Jun 20, 2024Leadership change8-K 5.02
- Feb 14, 2024Leadership change8-K 5.02
- Oct 2, 2023Leadership change8-K 5.02
- Jun 29, 2022Leadership change8-K 5.02
- Apr 1, 2022Leadership change8-K 5.02
- Dec 8, 2021Leadership change8-K 5.02
Latest shareholder vote results: May 7, 2026, including the say-on-pay vote.
Where the money went
2021–2025: $13.1bn returned to owners in buybacks and dividends, 51% of net income, and $1.4bn of pay in stock.
Show the figures
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $24.8bn | $26.6bn | $23.9bn | $23.9bn | $24.6bn |
| Net income | $6.4bn | $7.2bn | $4.8bn | $3.9bn | $3.6bn |
| Stock-based pay | $184.0m | $295.0m | $306.0m | $288.0m | $298.0m |
| Buybacks | — | $0 | $0 | $6.0bn | $3.1bn |
| Dividends | $742.0m | $818.0m | $821.0m | $768.0m | $878.0m |
| Diluted shares | 737m | 737m | 743m | 737m | 716m |
Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.